Why the study?
Do normal dietary intakes of protein and phosphate, or blood pressure levels, influence the progression of nephropathy in patients with Type 1 diabetes and hypertension?
Do normal dietary intakes of protein and phosphate, or blood pressure levels, influence the progression of nephropathy in patients with Type 1 diabetes and hypertension?
In patients with Type 1 diabetes and early nephropathy, systolic blood pressure is a major determinant of GFR decline, with levels ≤140 mmHg associated with stable renal function, whereas normal variations in dietary protein or phosphate have no significant impact.
Answers are grounded in this paper and cite their sources.
Prioritizes systolic BP control in type 1 nephropathy; observational data leaves open causal confirmation and dietary effects.
To examine the relationships between the normal dietary intakes of protein and phosphate, blood pressure, and the progression of diabetic nephropathy, we prospectively studied 20 Type 1 diabetic subjects of mean age 43 ± 10 years (SD) with early nephropathy (mean serum creatinine 115 ± 43 μmol l ‐1 ) over 1 year. Three‐monthly measurements of blood pressure, glycaemic control, and normal dietary intake (3‐day weighed food records) and 6‐monthly measurements of glomerular filtration rate (using a single injection of chromium 51 ‐EDTA) were made. GFR changed at a median rate of ‐0.89 ml min ‐1 1.73 m ‐2 month ‐1 (range + 0.85 to ‐2.55 ml min ‐1 1.73 m ‐2 month ‐1 ). Mean dietary protein intake (1.22 g kg ‐1 ; range 0.78 to 1.55 g kg ‐1 ) and phosphate intake (21.5 mg kg ‐1 ; range 14.1 to 30.4 mg kg ‐1 ) were not significantly related to the rate of change in GFR. Only mean systolic blood pressure was significantly related to change in GFR, and accounted for 45 % of the variability in GFR decline in the 18 subjects who completed the study ( r = 0.67; R 2 = 0.449; F 1,16 = 13.2; p ± 0.005; 95% confidence interval for r 0.336–0.867). A mean systolic blood pressure of 140 mmHg or below was associated with no significant decline in GFR over a median period of 13 months. Systolic blood pressure accounted for nearly half of the variability in GFR and a mean systolic pressure of 140 mmHg or below may represent a marker for ‘ideal’ blood pressure treatment. The normal wide variations in protein and phosphate intake between subjects did not significantly influence the rate at which renal function was lost.
No takes yet. Share an insight, caveat, or question.
Sampson et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: